Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04SHO
|
||||
| Former ID |
DIB001378
|
||||
| Drug Name |
NMI-1182
|
||||
| Synonyms |
Naproxen-related CINOD, NitroMed
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Terminated | [1] | ||
| Company |
NitroMed Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
[N+](=O)(OC(CO[N+](=O)[O-])COC(=O)C(c1cc2c(cc(cc2)OC)cc<br />1)C)[O-]
|
||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020060) | ||||
| REF 2 | NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor. Inflammopharmacology. 2005;12(5-6):521-34. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.